Incidence of central nervous system metastases in patients with HER2-positive metastatic breast cancer treated with pertuzumab, trastuzumab, and docetaxel: results from the randomized phase III study CLEOPATRA - Swain, S M; Baselga, J; Miles, D (Ann Oncol, 2014)
. doi:10.1093/annonc/mdu133